Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

Wallonia HealthSpaces

Facilities Designed to Make Healthcare More Accessible
Key Investment Information Sheet Terms & Conditions
Equity
€0
total amount raised in round

Offer conditions


The WALLONIA HEALTHSPACES 1A compartment of Spreds Finance would participate in the financing of WALLONIA HEALTHSPACES BV/SRL for an amount between €25,000 and €600,000 (the “Capital Increase”).

From the total amount raised during the offering period, Spreds Finance will use €1 per Participatory Note, subject to compliance with the conditions applicable to this investment.

The maximum offer amount of the offer: €100,000

Subscription price: Each Participatory Note has a nominal amount of €1. Added to this is a subscription cost of up to 5% of the nominal amount per Participatory Notes (or €0.05). The total subscription price of a Participatory Note is thus a maximum of €1.05. The minimum subscription amount is €500 (excluding subscription fees).

Conditions precedent of the offering:
The Notes will only be issued if, within 6 months from the Closing Date (the Effective Date), the following cumulative conditions precedent to the subscription of shares by Spreds Finance are met: 

  • The total amount of firm commitments to subscribe to this capital increase shall be at least €25,000 and not more than €600,000. 
  • The Capital Increase is carried out on the basis of a pre-money valuation of the company of maximum €300,000. 
  • Spreds Finance will participate in the capital increase for an amount equal to the result of the subscription to Participatory Notes of the WALLONIA HEALTHSPACES 1A compartment. This amount must be at least €25,000. 

Spreds Finance will verify whether these conditions are met no later than six months after the closing date (the “Effective Date”), i.e. 14/06/2027.

If one or more of these conditions are not met on that date, the Notes will not be issued and investors will be reimbursed their subscription amount no later than 15 working days after the Effective Date.


Valuation of the company


The company has set a pre-money valuation of €300,000.

It is based on an assessment of the company’s stage of development, the preparatory work already carried out, and the deployment potential of its primary healthcare infrastructure model.

The factors taken into consideration include the structuring of the business model, the preparation of the Pôle Santé Bonaparte pilot project, the strategic, operational and financial studies and documents prepared, as well as the steps already undertaken with healthcare professionals and financial partners. The founder’s experience in designing and coordinating healthcare facilities also contributes to the project’s ability to be implemented.

The amount retained takes into account the company’s still early stage, the absence of available historical financial information, and the risks associated with securing financing and obtaining the necessary authorisations, carrying out the works, and securing occupancy of the infrastructure. Projected revenues and expansion to other sites represent conditional prospects to which no guaranteed value is attributed.

This valuation applies to WHS prior to the new capital contributions. It does not correspond either to the total budget of the Bonaparte project or to the value of a property already owned. It constitutes a seed-stage valuation adopted for this financing round, rather than an independent valuation based on historical results.


Exit strategy


For investors, a potential exit from Wallonia HealthSpaces would primarily take the form of a strategic acquisition by a Belgian or European company specialising in healthcare infrastructure, healthcare property, social infrastructure or impact investment. Consolidation with an existing property portfolio or a majority investment by a specialised fund represents a second possible scenario.

Wallonia HealthSpaces is developing a model based on converting buildings into local healthcare infrastructure and generating recurring occupancy income through long-term agreements with legally independent healthcare operators. Its appeal to a potential acquirer would be based on a multi-site portfolio, contractual revenue, tangible property assets, a replicable development model and a specialised position in the primary healthcare market.

An exit could take place within approximately 5 to 8 years, between 2031 and 2034, once:

  • at least five healthcare infrastructure sites are structured or operational;
  • the model developed through Pôle Santé Bonaparte has been replicated across several sites;
  • annual occupancy income reaches at least €300,000;
  • annual EBITDA exceeds €250,000 to €300,000;
  • the agreements entered into with healthcare operators provide sufficient visibility over future income;
  • the process for identifying, financing, converting and making sites available has been standardised and can be replicated.

Potential acquirers include groups specialising in healthcare property, regulated property companies, social infrastructure funds, property or impact funds and European operators seeking to develop or consolidate their presence in the Belgian primary healthcare market.

Based on the current assumptions, a strategic acquisition could be valued by reference to the value of the property assets, contractual income and an indicative multiple of normalised EBITDA. For illustrative purposes, EBITDA of between €300,000 and €380,000 and a multiple of between 8x and 12x could correspond to an indicative enterprise value of approximately €2.4 million to €4.6 million.

The value ultimately available to shareholders would nevertheless depend on the remaining debt, the value of the assets, future financing rounds and the resulting dilution before the exit.

Depending on these factors, this scenario could provide investors with an indicative gross return of approximately 2x to 5x their initial investment. This estimate is purely illustrative and does not constitute a contractual target or guarantee of return.

An alternative scenario could involve the sale of individual assets or a portfolio of sites to a property fund or specialised operator, with or without Wallonia HealthSpaces continuing its development activities. A repurchase of the investors’ shares by the founder, management or the company could also be considered if operational cash flows and access to financing permit it.

This exit strategy reflects management’s current strategic assumptions and objectives. It is presented solely for illustrative purposes to provide investors with an overview of a potential future scenario. No guarantee can be given regarding the completion or timing of an exit, the availability of an acquirer or the achievement of the stated valuation and indicative return.

KPI 1 Number of structured or operational sites
The main indicator of Wallonia HealthSpaces’ ability to replicate its model and build a portfolio of sufficient scale to attract a strategic acquirer.

  • 2027: one operational site — Pôle Santé Bonaparte
  • 2030: three to five structured or operational sites
  • 2034 — exit-ready: eight to ten sites within a consolidated network

KPI 2 Annual occupancy income
The main indicator of recurring revenue growth and the financial visibility provided by agreements with healthcare operators.

  • 2027: approximately €45,600 in occupancy income
  • 2030: between €150,000 and €200,000 in occupancy income
  • 2034 — exit-ready: between €380,000 and €450,000 in occupancy income

KPI 3 Annual EBITDA
The main indicator of financial maturity, cash generation and Wallonia HealthSpaces’ potential valuation at the time of an exit.

  • 2027: approximately €40,600 in EBITDA
  • 2030: between €130,000 and €170,000 in EBITDA
  • 2034 — exit-ready: between €300,000 and €380,000 in EBITDA





Subscription period


Start date of the offering period: 07/10/2026
Scheduled end date of the subscription period: 14/12/2026 

Extension: Maximum extension of 3 months, until 14/03/2027

Conditions for extension: Spreds Finance may decide to extend the subscription period if the total amount of the orders contained in the subscription forms is at least €20,000 on 14/12/2026.

Early closing: The offer can be closed early once the minimum offer amount, of €25,000, has been reached. Early closure of the offer may also be decided if the total amount of orders contained in the subscription forms signed and transferred to Spreds Finance reaches the maximum amount of the offer.

Consequences if the target capital is not raised by the deadline: If the target capital is not raised, the Participatory Notes will not be issued and all commitments related to this offer will be cancelled. Investors will be reimbursed for their respective Subscription Amount no later than 15 business days after the Deadline. Investors will not incur any fees or expenses as a result of the offer not reaching the targeted amount.

Raise summary

Crowd investments €0
Committed by others €0
Amount raised €0
Minimum round €25,000
Maximum round €600,000
Shares in the company (total round) 66.667%
Pre-money valuation €300,000
Post-money valuation min. €325,000
Post-money valuation max. €900,000